Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mikhail Daya Attie

Dentist, Oral and Maxillofacial Surgery Davie, FL Doctor of Dentistry

NPI 1861878621 CMS profile 1353149

3200 S University Dr, Davie, FL 33328

Open in the dashboard

General payments

$32,520

65 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mikhail Daya Attie of Davie, FL is reported in the CMS Open Payments database as having received $32,520 across 65 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,693 17
2024 General $1,002 11
2023 General $1,939 13
2022 General $685 7
2021 General $812 6
2020 General $154 4
2019 General $25,235 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mikhail Daya Attie
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Mikhail Daya Attie were reported at $2,693. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Mikhail Daya Attie Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $25,235 $142 $50–$420 $163
2020 $154 $96 $36–$277 $114
2021 $812 $138 $45–$419 $132
2022 $685 $144 $48–$367 $149
2023 $1,939 $153 $55–$399 $160
2024 $1,002 $152 $50–$400 $164
2025 $2,693 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. KLS-Martin L.P. $25,596 8 payments
  2. Stryker Corporation $3,926 27 payments
  3. Straumann USA LLC $2,383 20 payments
  4. Zimvie Inc. $385 5 payments
  5. Zimmer Biomet Holdings, Inc. $65 1 payment
  6. Keystone Dental Inc. $62 1 payment
  7. Nobel Biocare USA $58 1 payment
  8. Galderma Laboratories, L.P. $32 1 payment
  9. Philips Electronics North America Corporation $12 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Grant $25,000 2 payments
  2. Food and Beverage $2,745 42 payments
  3. Travel and Lodging $2,717 13 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,188 4 payments
  5. Gift $659 2 payments
  6. Education $150 1 payment
  7. Entertainment $62 1 payment
Products named General payments · program years 2019–2025
  1. NA $1,506 7 payments
  2. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM Craniomaxillofacial $893 7 payments
  3. VSP SYSTEM, VSP CRANIAL $618 8 payments
  4. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM Craniomaxillofacial $491 3 payments
  5. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM Craniomaxillofacial $243 1 payment
  6. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM Craniomaxillofacial $175 1 payment
  7. BioMend $150 1 payment
  8. STRYKER VARISPEED $124 1 payment
  9. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM Craniomaxillofacial $70 1 payment
  10. Bellatek $65 1 payment
  11. Other $349 8 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

552

Median for Oral Surgery (Dentist only): 288

Drug cost

$1,939

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

7.6%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Chlorhexidine Gluconate Generic 181 $767
Amoxicillin Generic 138 $412
Ibuprofen Generic 152 $398
Azithromycin Generic 39 $204
Acetaminophen-Codeine Acetaminophen With Codeine Brand 42 $158

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record